Home LiteratureArticle Details
PMID: 2811381 Published · ppublish English Journal Article

Results of surgical treatment in 6,123 cases of carcinoma of the esophagus and gastric cardia.

Journal of surgical oncology ·Vol. 42 ·No. 3 ·1989-11-00 ·Pages 170-4

Shao LF, Gao ZG, Yang NP, Wei GQ, Wang YD, Cheng CP

Abstract

Six thousand one hundred twenty-three cases of carcinoma of the esophagus and gastric cardia were treated surgically from 1965 to 1985. Overall resectability was 89.9%. Postoperative mortality was 3%, and incidence of postoperative complication, 10.3%. Follow-up rate was 91.3%, with 5 year survival of 36.8% (esophageal nearly twice that of gastric cardia), and 10 year survival of 17.2%. Factors affecting long-term survival were clinicopathologic staging and preoperative irradiation. Early discovery and timely treatment are the key to high resectability and improved long-term survival. More efficacious combined therapies are needed for the predominant late cases. We propose more radical resection because of the multifocal tendency of esophageal and extensive submucosal infiltration of cardia carcinoma. Continuing refinements of surgical technique helped to reduce postoperative leakage and structure.

MeSH Terms
Adult Aged Cardia/surgery Combined Modality Therapy Esophageal Neoplasms/mortality,radiotherapy,surgery Humans Middle Aged Postoperative Complications Stomach Neoplasms/mortality,radiotherapy,surgery
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shao L F
Department of Thoracic Surgery, Henan Cancer Institute & Hospital, Zhengzhou, Henan Province, People's Republic of China.
Gao Z G
Yang N P
Wei G Q
Wang Y D
Cheng C P
Article Info
Journal
Journal of surgical oncology
Abbr.
J Surg Oncol
ISSN
0022-4790
Published
1989-11-00
Pages
170-4
Language
English
Region
United States
NLM ID
0222643
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com